In this review, we argue that induction of CD8+ T cell peripheral tolerance within the draining lymph node is a major contributor to tumor immune evasion, and that disruption of this immune checkpoint may contribute to the efficacy of cancer immunotherapy. This evidence concerns the gene CD8A and cancer.